Literature DB >> 18632984

Transcription-coupled DNA double-strand breaks are mediated via the nucleotide excision repair and the Mre11-Rad50-Nbs1 complex.

Josée Guirouilh-Barbat1, Christophe Redon, Yves Pommier.   

Abstract

The cellular activity of Yondelis (trabectedin, Ecteinascidin 743, Et743) is known to depend on transcription-coupled nucleotide excision repair (TCR). However, the subsequent cellular effects of Et743 are not fully understood. Here we show that Et743 induces both transcription- and replication-coupled DNA double-strand breaks (DSBs) that are detectible by neutral COMET assay and as gamma-H2AX foci that colocalize with 53BP1, Mre11, Ser(1981)-pATM, and Thr(68)-pChk2. The transcription coupled-DSBs (TC-DSBs) induced by Et743 depended both on TCR and Mre11-Rad50-Nbs1 (MRN) and were associated with DNA-PK-dependent gamma-H2AX foci. In contrast to DNA-PK, ATM phosphorylated H2AX both in NER-proficient and -deficient cells, but its full activation was dependent on H2AX as well as DNA-PK, suggesting a positive feedback loop: DNA-PK-gamma-H2AX-ATM. Knocking-out H2AX or inactivating DNA-PK reduced Et743's antiproliferative activity, whereas ATM and MRN tended to act as survival factors. Our results highlight the interplays between ATM and DNA-PK and their impacts on H2AX phosphorylation and cell survival. They also suggest that gamma-H2AX may serve as a biomarker in patients treated with Et743 and that molecular profiling of tumors for TCR, MRN, ATM, and DNA-PK might be useful to anticipate tumor response to Et743 treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632984      PMCID: PMC2526702          DOI: 10.1091/mbc.e08-02-0215

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  69 in total

1.  Genomic instability in mice lacking histone H2AX.

Authors:  Arkady Celeste; Simone Petersen; Peter J Romanienko; Oscar Fernandez-Capetillo; Hua Tang Chen; Olga A Sedelnikova; Bernardo Reina-San-Martin; Vincenzo Coppola; Eric Meffre; Michael J Difilippantonio; Christophe Redon; Duane R Pilch; Alexandru Olaru; Michael Eckhaus; R Daniel Camerini-Otero; Lino Tessarollo; Ferenc Livak; Katia Manova; William M Bonner; Michel C Nussenzweig; André Nussenzweig
Journal:  Science       Date:  2002-04-04       Impact factor: 47.728

2.  Bcl2 negatively regulates DNA double-strand-break repair through a nonhomologous end-joining pathway.

Authors:  Qinhong Wang; Fengqin Gao; W Stratford May; Yangde Zhang; Tammy Flagg; Xingming Deng
Journal:  Mol Cell       Date:  2008-02-29       Impact factor: 17.970

3.  Xeroderma pigmentosum genes: functions inside and outside DNA repair.

Authors:  Kaoru Sugasawa
Journal:  Carcinogenesis       Date:  2008-01-03       Impact factor: 4.944

4.  Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy.

Authors:  R Garcia-Carbonero; J G Supko; J Manola; M V Seiden; D Harmon; D P Ryan; M T Quigley; P Merriam; J Canniff; G Goss; U Matulonis; R G Maki; T Lopez; T A Puchalski; M A Sancho; J Gomez; C Guzman; J Jimeno; G D Demetri
Journal:  J Clin Oncol       Date:  2004-04-15       Impact factor: 44.544

5.  Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex.

Authors:  Travis H Stracker; Christian T Carson; Matthew D Weitzman
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

Review 6.  Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action.

Authors:  Gregory J Aune; Takahisa Furuta; Yves Pommier
Journal:  Anticancer Drugs       Date:  2002-07       Impact factor: 2.248

Review 7.  Preclinical and clinical results with the natural marine product ET-743.

Authors:  Maurizio D'Incalci; José Jimeno
Journal:  Expert Opin Investig Drugs       Date:  2003-11       Impact factor: 6.206

8.  Structural and functional analysis of Mre11-3.

Authors:  L Matthew Arthur; Karin Gustausson; Karl-Peter Hopfner; Christian T Carson; Travis H Stracker; Annette Karcher; Diana Felton; Matthew D Weitzman; John Tainer; James P Carney
Journal:  Nucleic Acids Res       Date:  2004-03-26       Impact factor: 16.971

9.  Ecteinascidin-743 inhibits activated but not constitutive transcription.

Authors:  Debbie Friedman; Zhen Hu; E Anders Kolb; Barbara Gorfajn; Kathleen W Scotto
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

10.  DNA damage-induced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53.

Authors:  Richard A Woo; Melissa T Jack; Yang Xu; Sandeep Burma; David J Chen; Patrick W K Lee
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

View more
  34 in total

Review 1.  Ecteinascidins. A review of the chemistry, biology and clinical utility of potent tetrahydroisoquinoline antitumor antibiotics.

Authors:  V H Le; M Inai; R M Williams; T Kan
Journal:  Nat Prod Rep       Date:  2015-02       Impact factor: 13.423

2.  A retrospective pooled analysis of trabectedin safety in 1,132 patients with solid tumors treated in phase II clinical trials.

Authors:  Axel Le Cesne; Alejandro Yovine; Jean-Yves Blay; Suzette Delaloge; Robert G Maki; Jean-Louis Misset; Pilar Frontelo; Antonio Nieto; Juhui James Jiao; George D Demetri
Journal:  Invest New Drugs       Date:  2011-04-12       Impact factor: 3.850

3.  Lsm1 promotes genomic stability by controlling histone mRNA decay.

Authors:  Ana B Herrero; Sergio Moreno
Journal:  EMBO J       Date:  2011-04-12       Impact factor: 11.598

4.  DNA double-strand breaks and ATM activation by transcription-blocking DNA lesions.

Authors:  Olivier Sordet; Asako J Nakamura; Christophe E Redon; Yves Pommier
Journal:  Cell Cycle       Date:  2010-01-02       Impact factor: 4.534

5.  Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors.

Authors:  Alessandro Villanucci; Ketty Tavella; Laura Vannini; Virginia Rossi; Stefania Nobili; Gianni Amunni; Teresita Mazzei; Enrico Mini
Journal:  Mol Clin Oncol       Date:  2018-10-01

6.  Ecteinascidin 743 interferes with the activity of EWS-FLI1 in Ewing sarcoma cells.

Authors:  Patrick J Grohar; Laurie B Griffin; Choh Yeung; Qing-Rong Chen; Yves Pommier; Chand Khanna; Javed Khan; Lee J Helman
Journal:  Neoplasia       Date:  2011-02       Impact factor: 5.715

7.  Single-Molecule Imaging Reveals How Mre11-Rad50-Nbs1 Initiates DNA Break Repair.

Authors:  Logan R Myler; Ignacio F Gallardo; Michael M Soniat; Rajashree A Deshpande; Xenia B Gonzalez; Yoori Kim; Tanya T Paull; Ilya J Finkelstein
Journal:  Mol Cell       Date:  2017-08-31       Impact factor: 17.970

8.  Zalypsis (PM00104) is a potent inducer of gamma-H2AX foci and reveals the importance of the C ring of trabectedin for transcription-coupled repair inhibition.

Authors:  Josée Guirouilh-Barbat; Smitha Antony; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2009-07-07       Impact factor: 6.261

9.  Induction of glutathione-dependent DNA double-strand breaks by the novel anticancer drug brostallicin.

Authors:  Josée Guirouilh-Barbat; Yong-Wei Zhang; Yves Pommier
Journal:  Mol Cancer Ther       Date:  2009-07-07       Impact factor: 6.261

10.  High-throughput sequencing reveals principles of adeno-associated virus serotype 2 integration.

Authors:  Tyler Janovitz; Isaac A Klein; Thiago Oliveira; Piali Mukherjee; Michel C Nussenzweig; Michel Sadelain; Erik Falck-Pedersen
Journal:  J Virol       Date:  2013-05-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.